-
Mashup Score: 1
The Australian scientist sees his illness not as a death sentence, but an opportunity to transform treatment for a stubbornly intractable form of cancer.
Source: www.bnnbloomberg.caCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Sex-biased T-cell exhaustion in glioblastoma is, in part, regulated by T cell–intrinsic factors, such as the X chromosome inactivation escape gene Kdm6a, which highlights the potential for a precision therapy approach based on patient biologic sex.
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI from the latest issue— Sex-biased T cell Exhaustion Drives Differential Immune Responses in #Glioblastoma, by @JuyeunLee31, @JustinLathia et al. https://t.co/FoK7cLX20W @ClevelandClinic @caseccc https://t.co/ePdy4nxHUJ
-
-
Mashup Score: 0The EU Funded Project LEGATO Officially Started - 8 month(s) ago
We are delighted to announce the official start of LEGATO, a pragmatic phase III clinical trial focusing on recurrent Glioblastoma.
Source: www.eortc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎉We are delighted to announce the official start of @HorizonEU funded @Legato_Horizon #ClinicalTrial on recurrent #Glioblastoma🧠, in collaboration with Syreon Research Institute. More: https://t.co/IYT8BJAxTE @EU_Commission #LEGATO_Horizon #HorizonEurope #EUCancerMission https://t.co/3f4qIfzdMW
-
-
Mashup Score: 9Single‐cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma - 8 month(s) ago
scRNA-seq and live-imaging in zebrafish avatars were used to study the complex and dynamic interplay between GBM tumor cells and GAMs, and provide fresh perspectives and opportunities for discovering…
Source: www.embopress.orgCategories: General Medicine News, Latest HeadlinesTweet-
Zebrafish avatars can help tailor #glioblastoma therapies https://t.co/q77NTWvHYm https://t.co/zwg7227iTu
-
-
Mashup Score: 0CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis - PubMed - 8 month(s) ago
Malignant tumors exhibit heterogeneous metabolic reprogramming, hindering the identification of translatable vulnerabilities for metabolism-targeted therapy. How molecular alterations in tumors promote metabolic diversity and distinct targetable dependencies remains poorly defined. Here we create a …
Source: pubmed.ncbi.nlm.nih.govCategories: Latest Headlines, Oncologists1Tweet-
SCI member @SJD956 & others conducted a comprehensive analysis of 156 #glioblastoma tumors, revealing the impact of CDKN2A deletion on the lipidome, redistributing polyunsaturated fatty acids, and increasing lipid peroxidation. https://t.co/y888Y9cdSC https://t.co/2NzEUD71cg
-
-
Mashup Score: 7
Sex-biased T-cell exhaustion in glioblastoma is, in part, regulated by T cell–intrinsic factors, such as the X chromosome inactivation escape gene Kdm6a, which highlights the potential for a precision therapy approach based on patient biologic sex.
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From the September issue: Sex-biased T cell Exhaustion Drives Differential Immune Responses in #Glioblastoma, by @JuyeunLee31, @JustinLathia et al. https://t.co/hETntUYuXu @ClevelandClinic @caseccc https://t.co/yyeyNtZoEJ
-
-
Mashup Score: 0White Matter Tract Density Index Predicts Presurgical Outcomes in Patients With Glioblastoma : Neurology Today - 8 month(s) ago
An abstract is unavailable.
Source: journals.lww.comCategories: Latest Headlines, NeurologyTweet-
Via @JAMANeuro: A new white matter tract density index can reliably indicate presurgical outcomes in patients with #glioblastoma, suggesting that researchers and clinicians may want to incorporate it into their work: https://t.co/LIlMniz9Sp #NeuroTwitter @AANMember @PNC_UniPD https://t.co/KG4t2C3XcU
-
-
Mashup Score: 3Dr. Fahar Merchant Discusses a Treatment to Combat Glioblastoma - 8 month(s) ago
Home > Oncology > Dr. Fahar Merchant Discusses a Treatment to Combat Glioblastoma Medicenna, a clinical-stage immunotherapy company, has made significant progress in the development of MDNA11 and MDNA55, which utilize engineered interleukins, known as Superkines, to modulate the i mmune system and combat challenging diseases like recurrent glioblastoma multiforme—an invariably fatal form of brain cancer—and other end-stage cancers. MDNA55, an empowered Superkine, delivers a potent bacterial toxin directly
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet-
Dr. Fahar Merchant discusses a novel treatment which improves overall survival in glioblastoma. #GBM #glioblastoma #braincancer #neurology https://t.co/PtVTLHko3N https://t.co/NJohiKD1Bx
-
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Novel research from @BrighamWomens has developed a promising new cell #therapy to eliminate established #glioblastoma tumors and to act as a #cancer vaccine to induce long-term #immunity. Read more about the study: https://t.co/Lasd2daDSp https://t.co/z7MBwDJcaO
-
-
Mashup Score: 9Glioma survivor thrives after treatment at MD Anderson - 8 month(s) ago
After undergoing a craniotomy at MD Anderson to remove a high-grade glioma, Grace Jou is back to living life to its fullest.
Source: www.mdanderson.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Grace Jou shares why she’s grateful for MD Anderson and how she stayed positive during and after treatment: “I think I am the best-case scenario.” https://t.co/xjFXqh0QvN @DrJeffWeinberg #glioblastoma #BrainTumor #EndCancer
-
In the search for better glioblastoma treatment, brain cancer researchers face many challenges. “But if we don’t push it, those patients are not going to get better,” says our Dr. Hussein Tawbi. https://t.co/8gwVADplRZ @Bloomberg @HTawbi_MD #glioblastoma #EndCancer